Biochemical response to ursodeoxycholic acid predicts histologic primary biliary cholangitis progression

被引：0

作者：

Fujinaga, Yukihisa ^{[1
]}

Namisaki, Tadashi ^{[1
]}

Moriya, Kei ^{[1
]}

Kitade, Mitsuteru ^{[1
]}

Kawaratani, Hideto ^{[1
]}

Kaji, Kosuke ^{[1
]}

Okura, Yasushi ^{[1
]}

Seki, Kenichiro ^{[1
]}

Takaya, Hiroaki ^{[1
]}

Sawada, Yasuhiko ^{[1
]}

Akahane, Takemi ^{[1
]}

Nishimura, Norihisa ^{[1
]}

Sato, Shinya ^{[1
]}

Shimozato, Naotaka ^{[1
]}

Saikawa, Soichiro ^{[1
]}

Nakanishi, Keisuke ^{[1
]}

Kubo, Takuya ^{[1
]}

Furukawa, Masanori ^{[1
]}

Yoshiji, Hitoshi ^{[1
]}

机构：

[1] Nara Med Univ, Dept Internal Med 3, Kashihara, Nara, Japan

来源：

HEPATOLOGY | 2017年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

348

引用

页码：196A / 196A

页数：1

共 50 条

[21] Treatment in primary biliary cholangitis: Beyond ursodeoxycholic acid
van Hooff, M. C.
Werner, E.
van der Meer, A. J.
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 124 : 14 - 21
[22] Primary biliary cholangitis: histological and clinical liver progression in non responders to ursodeoxycholic acid
Cacciato, V.
Benizzelli, G.
Grillo, F.
Borro, P.
Marenco, S.
Pasta, A.
Picciotto, A.
Labanca, S.
DIGESTIVE AND LIVER DISEASE, 2020, 52 : E35 - E36
[23] Characteristics associated with non-response to ursodeoxycholic acid in primary biliary cholangitis
Dias, T.
Santos, A.
Carvalho, J.
Bento-Miranda, M.
Sant'anna, M.
Calinas, F.
Loureiro, R.
Martins, A.
Alexandrino, G.
Cotrim, I.
Martins, C.
Presa, J.
Mesquita, M.
Nunes, J.
Ferreira, A.
Horta e Vale, A.
Alves, A. L. C.
Pedroto, I.
Maia, L.
Banhudo, A.
Mocanu, I.
Laranjo, A. M.
Lopes, S.
Liberal, R.
Fonseca, C.
Oliveira, J.
Gomes, M.
Cortez-Pinto, H.
JOURNAL OF HEPATOLOGY, 2018, 68 : S633 - S633
[24] Fenofibrate in Primary Biliary Cholangitis Patients With Inadequate Response to Ursodeoxycholic Acid (UDCA)
Khaykis, Inessa
Sherman, Alex
Tobias, Hillel
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S501 - S501
[25] Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis
Poupon, RE
Lindor, KD
Parés, A
Chazouillères, O
Poupon, R
Heathcote, EJ
JOURNAL OF HEPATOLOGY, 2003, 39 (01) : 12 - 16
[26] Bezafibrate for primary biliary Cholangitis "Bezafibrate in combination with ursodeoxycholic acid in primary biliary cholangitis (BEZURSO) trial"
Klose, G.
Nitschmann, S.
INTERNIST, 2018, 59 (12): : 1344 - 1346
[27] Evidence for the association between IgG-antimitochondrial antibody and biochemical response to ursodeoxycholic acid treatment in primary biliary cholangitis
Tang, Libo
Zhong, Ruihua
He, Xuanqiu
Wang, Weibin
Liu, Jinhong
Zhu, Youfu
Li, Yongyin
Hou, Jinlin
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (03) : 659 - 666
[28] Good performance of the biochemical response criteria after three months of ursodeoxycholic acid treatment in patients with primary biliary cholangitis
Patricia Llovet, Laura
Reig, Anna
Ortiz, Oswaldo
Carlota Londono, Maria
Pares, Albert
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E401 - E401
[29] Distinct signatures of gut microbiota and metabolites in primary biliary cholangitis with poor biochemical response after ursodeoxycholic acid treatment
Han, Weijia
Song, Ting
Huang, Zhongyi
Liu, Yanmin
Xu, Bin
Huang, Chunyang
CELL AND BIOSCIENCE, 2024, 14 (01):
[30] Low platelet count influences the performance of the different biochemical criteria of ursodeoxycholic acid therapy response in primary biliary cholangitis
Reig, A.
Pares, A.
JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S355 - S355

← 1 2 3 4 5 →